E. Assenat, S. Gerbal-chaloin, D. Larrey, J. Saric, J. Fabre et al., Interleukin 1? inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance, Hepatology, vol.280, issue.4, pp.951-960, 2004.
DOI : 10.1002/hep.20387

P. Balaguer, F. Francois, F. Comunale, H. Fenet, A. Boussioux et al., Reporter cell lines to study the estrogenic effects of xenoestrogens, Science of The Total Environment, vol.233, issue.1-3, pp.47-56, 1999.
DOI : 10.1016/S0048-9697(99)00178-3

G. Bertilsson, J. Heidrich, K. Svensson, M. Asman, L. Jendeberg et al., Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction, Proceedings of the National Academy of Sciences, vol.23, issue.3, pp.12208-12213, 1998.
DOI : 10.1016/0092-8674(95)90194-9

T. Cole, J. Blendy, A. Monaghan, K. Krieglstein, W. Schmid et al., Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation., Genes & Development, vol.9, issue.13, pp.1608-1621, 1995.
DOI : 10.1101/gad.9.13.1608

N. Debeljak, M. Fink, and D. Rozman, Many facets of mammalian lanosterol 14??-demethylase from the evolutionarily conserved cytochrome P450 family CYP51, Archives of Biochemistry and Biophysics, vol.409, issue.1, pp.159-171, 2003.
DOI : 10.1016/S0003-9861(02)00418-6

V. Deroche-gamonet, I. Sillaber, B. Aouizerate, R. Izawa, M. Jaber et al., The glucocorticoid receptor as a potential target to reduce cocaine abuse, J Neurosci, vol.23, pp.4785-4790, 2003.

Z. Dvorak, M. Modriansky, L. Pichard-garcia, P. Balaguer, M. Vilarem et al., Colchicine Down-Regulates Cytochrome P450 2B6, 2C8, 2C9, and 3A4 in Human Hepatocytes by Affecting Their Glucocorticoid Receptor-Mediated Regulation, Molecular Pharmacology, vol.64, issue.1, pp.160-169, 2003.
DOI : 10.1124/mol.64.1.160

S. Gerbal-chaloin, M. Daujat, J. Pascussi, L. Pichard-garcia, M. Vilarem et al., Transcriptional Regulation of CYP2C9 Gene: ROLE OF GLUCOCORTICOID RECEPTOR AND CONSTITUTIVE ANDROSTANE RECEPTOR, Journal of Biological Chemistry, vol.277, issue.1, pp.209-217, 2002.
DOI : 10.1074/jbc.M107228200

S. Gerbal-chaloin, L. Pichard-garcia, J. Fabre, A. Sa-cunha, L. Poellinger et al., Role of CYP3A4 in the regulation of the aryl hydrocarbon receptor by omeprazole sulphide, Cellular Signalling, vol.18, issue.5, pp.740-750, 2006.
DOI : 10.1016/j.cellsig.2005.07.007

N. Goeders, R. Peltier, and G. Guerin, Ketoconazole reduces low dose cocaine self-administration in rats, Drug and Alcohol Dependence, vol.53, issue.1, pp.67-77, 1998.
DOI : 10.1016/S0376-8716(98)00108-2

W. Huang, J. Zhang, S. Chua, M. Qatanani, Y. Han et al., Induction of bilirubin clearance by the constitutive androstane receptor (CAR), Proceedings of the National Academy of Sciences, vol.50, issue.2, 2003.
DOI : 10.1136/gut.50.2.259

C. Jefcoate, [27] Measurement of substrate and inhibitor binding to microsomal cytochrome P-450 by optical-difference spectroscopy, Methods Enzymol, vol.52, pp.258-279, 1978.
DOI : 10.1016/S0076-6879(78)52029-6

M. Johansson, N. Johansson, and B. Lund, Xenobiotics and the Glucocorticoid Receptor: Additive Antagonistic Effects on Tyrosine Aminotransferase Activity in Rat Hepatoma Cells, Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology, vol.203, issue.4, pp.309-315, 2005.
DOI : 10.1016/S0300-483X(97)03620-2

H. Kast, B. Goodwin, P. Tarr, S. Jones, A. Anisfeld et al., Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor, Journal of Biological Chemistry, vol.277, issue.4, pp.2908-2915, 2002.
DOI : 10.1074/jbc.M109326200

J. Lehmann, D. Mckee, M. Watson, T. Willson, J. Moore et al., The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions., Journal of Clinical Investigation, vol.102, issue.5, pp.1016-1023, 1998.
DOI : 10.1172/JCI3703
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC508967

D. Loose, P. Kan, M. Hirst, R. Marcus, and D. Feldman, Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes., Journal of Clinical Investigation, vol.71, issue.5, pp.1495-1499, 1983.
DOI : 10.1172/JCI110903
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC437014

D. Loose, E. Stover, and D. Feldman, Ketoconazole binds to glucocorticoid receptors and exhibits glucocorticoid antagonist activity in cultured cells., Journal of Clinical Investigation, vol.72, issue.1, pp.404-408, 1983.
DOI : 10.1172/JCI110982
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1129197

J. Maglich, D. Parks, L. Moore, J. Collins, B. Goodwin et al., Identification of a Novel Human Constitutive Androstane Receptor (CAR) Agonist and Its Use in the Identification of CAR Target Genes, Journal of Biological Chemistry, vol.278, issue.19, pp.17277-17283, 2003.
DOI : 10.1074/jbc.M300138200

D. Mangelsdorf, C. Thummel, M. Beato, P. Herrlich, G. Schutz et al., The nuclear receptor superfamily: The second decade, Cell, vol.83, issue.6, pp.835-839, 1995.
DOI : 10.1016/0092-8674(95)90199-X

R. Mcquade and A. Young, Future therapeutic targets in mood disorders: the glucocorticoid receptor, The British Journal of Psychiatry, vol.177, issue.5, pp.390-395, 2000.
DOI : 10.1192/bjp.177.5.390

L. Moore, D. Parks, S. Jones, R. Bledsoe, T. Consler et al., Orphan Nuclear Receptors Constitutive Androstane Receptor and Pregnane X Receptor Share Xenobiotic and Steroid Ligands, Journal of Biological Chemistry, vol.275, issue.20, pp.15122-15127, 2000.
DOI : 10.1074/jbc.M001215200

W. Oh, Secondary hormonal therapies in the treatment of prostate cancer, Urology, vol.60, issue.3, pp.87-92, 2002.
DOI : 10.1016/S0090-4295(02)01581-9

J. Pascussi, M. Busson-le-coniat, P. Maurel, and M. Vilarem, Transcriptional Analysis of the Orphan Nuclear Receptor Constitutive Androstane Receptor (NR1I3) Gene Promoter: Identification of a Distal Glucocorticoid Response Element, Molecular Endocrinology, vol.17, issue.1, pp.42-55, 2003.
DOI : 10.1210/me.2002-0244

J. Pascussi, L. Drocourt, S. Gerbal-chaloin, J. Fabre, P. Maurel et al., gene expression in human hepatocytes, European Journal of Biochemistry, vol.20, issue.2-3, pp.6346-6358, 2001.
DOI : 10.1046/j.0014-2956.2001.02540.x

J. Pascussi, L. Drocourt, J. Fabre, P. Maurel, and M. Vilarem, Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators, Mol Pharmacol, vol.58, pp.361-372, 2000.

J. Pascussi, S. Gerbal-chaloin, L. Drocourt, E. Assenat, D. Larrey et al., Cross-talk between xenobiotic detoxication and other signalling pathways: clinical and toxicological consequences, Xenobiotica, vol.272, issue.7, pp.633-664, 2004.
DOI : 10.1126/science.1073502

J. Pascussi, S. Gerbal-chaloin, J. Fabre, P. Maurel, and M. Vilarem, Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation, Mol Pharmacol, vol.58, pp.1441-1450, 2000.

L. Pichard-garcia, S. Gerbal-chaloin, J. Ferrini, J. Fabre, and P. Maurel, Use of long-term cultures of human hepatocytes to study cytochrome P450 gene expression, Methods Enzymol, vol.357, pp.311-321, 2002.
DOI : 10.1016/S0076-6879(02)57689-8

L. Pulaski, K. Kania, M. Ratajewski, T. Uchiumi, M. Kuwano et al., Differential regulation of the human MRP2 and MRP3 gene expression by glucocorticoids, The Journal of Steroid Biochemistry and Molecular Biology, vol.96, issue.3-4, pp.229-234, 2005.
DOI : 10.1016/j.jsbmb.2005.03.004

M. Schulz, M. Eggert, A. Baniahmad, A. Dostert, T. Heinzel et al., RU486-induced Glucocorticoid Receptor Agonism Is Controlled by the Receptor N Terminus and by Corepressor Binding, Journal of Biological Chemistry, vol.277, issue.29, pp.26238-26243, 2002.
DOI : 10.1074/jbc.M203268200

T. Sueyoshi, T. Kawamoto, I. Zelko, P. Honkakoski, and M. Negishi, The Repressed Nuclear Receptor CAR Responds to Phenobarbital in Activating the Human CYP2B6 Gene, Journal of Biological Chemistry, vol.274, issue.10, pp.6043-6046, 1999.
DOI : 10.1074/jbc.274.10.6043

J. Sugatani, S. Nishitani, K. Yamakawa, K. Yoshinari, T. Sueyoshi et al., Transcriptional Regulation of Human UGT1A1 Gene Expression: Activated Glucocorticoid Receptor Enhances constitutive Androstane Receptor/Pregnane X Receptor-Mediated UDP-Glucuronosyltransferase 1A1 Regulation with Glucocorticoid Receptor-Interacting Protein 1, Molecular Pharmacology, vol.67, issue.3, pp.845-855, 2005.
DOI : 10.1124/mol.104.007161

A. Takeshita, M. Taguchi, N. Koibuchi, and Y. Ozawa, Putative Role of the Orphan Nuclear Receptor SXR (Steroid and Xenobiotic Receptor) in the Mechanism of CYP3A4 Inhibition by Xenobiotics, Journal of Biological Chemistry, vol.277, issue.36, pp.32453-32458, 2002.
DOI : 10.1074/jbc.M111245200

H. Vanden-bossche, L. Koymans, and H. Moereels, P450 inhibitors of use in medical treatment: Focus on mechanisms of action, Pharmacology & Therapeutics, vol.67, issue.1, pp.79-100, 1995.
DOI : 10.1016/0163-7258(95)00011-5

K. Venkatakrishnan, L. Von-moltke, and D. Greenblatt, Effects of the Antifungal Agents on Oxidative Drug Metabolism, Clinical Pharmacokinetics, vol.277, issue.2, pp.111-180, 2000.
DOI : 10.2165/00003088-200038020-00002

Q. Wang, J. Blackford, . Jr, L. Song, Y. Huang et al., Equilibrium Interactions of Corepressors and Coactivators with Agonist and Antagonist Complexes of Glucocorticoid Receptors, Molecular Endocrinology, vol.18, issue.6, pp.1376-1395, 2004.
DOI : 10.1210/me.2003-0421

J. Whitlock and . Jr, INDUCTION OF CYTOCHROME P4501A1, Annual Review of Pharmacology and Toxicology, vol.39, issue.1, pp.103-125, 1999.
DOI : 10.1146/annurev.pharmtox.39.1.103

T. Wintermantel, S. Berger, E. Greiner, and G. Schutz, Evaluation of steroid receptor function by gene targeting in mice, The Journal of Steroid Biochemistry and Molecular Biology, vol.93, issue.2-5, pp.107-112, 2005.
DOI : 10.1016/j.jsbmb.2004.12.033

O. Wolkowitz, V. Reus, T. Chan, F. Manfredi, W. Raum et al., Antiglucocorticoid treatment of depression: double-blind ketoconazole, Biological Psychiatry, vol.45, issue.8, pp.1070-1074, 1999.
DOI : 10.1016/S0006-3223(98)00267-4

C. Xu, C. Li, and A. Kong, Induction of phase I, II and III drug metabolism/transport by xenobiotics, Archives of Pharmacal Research, vol.182, issue.481, pp.249-268, 2005.
DOI : 10.1007/BF02977789